Stay updated with breaking news from Jay Grobler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK, Sept — Laboratory studies show that Merck & Co’s experimental oral Covid-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmissible Delta, the company said on Wednesday. Since molnupiravir does...
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZA2QNF656ZF5JKWWSWG25B64QY.JPG)
Merck está realizando dos ensayos de fase III del antiviral que está desarrollando con Ridgeback Biotherapeutics: uno para el tratamiento del COVID-19 y otro como preventivo.
Dr. Anthony Fauci, asked about Wall Street Journal reporting that expanded approval may not come next month depending on when the companies file a formal application, said the Food and Drug Administration was working expeditiously and that "if it goes into November, that's because it's necessary." Merck says research shows its COVID-19 pill works against variants Laboratory studies show that Merck & Co's experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective against known variants of the coronavirus, including the dominant, highly transmi...
As Merck & Co and Pfizer Inc prepare to report clinical trial results for experimental Covid-19 antiviral pills, rivals are lining up with what they hope will prove to be more potent and convenient oral treatments of their own. Enanta Pharmaceuticals, Pardes Biosciences, Japan's Shionogi & Co Ltd and Novartis AG said they have designed antivirals that specifically target the...